That is where we actually don't agree. I do not believe progress is being made. I know they are currently stuck in a place that they must have know would come some day. Even if the amount of material needed for Tox was a surprise because of the extreme safety of the cides (a statement that I personally think is absolute hog wash since they knew they needed Kg levels WAY before the completion of small animal Tox at BASi, particularly because that is specifically what the company said in public filings) they certainly knew they would need to produce in quantities above 200mg to have a commercially viable product.
I am on the record saying Tox will not be completed this year and next.
For those who care to look it up, I had a contest recently where I asked what would occur first and one of the options was the introduction of another cide, besides flucide, to take the focus off the stagnation of Flucide.
And now look at the topical herpes cream that is the new flavor of the month. Denguecide, ekccide, hivcide...and now herpecide. Alll were heralded as the next big thing. And yet, here we are. And even Seymour can't keep it straight. When asked about how the new cide is administered he said occularly. I know he knows herpecide is topical and not occular. What he didn't know was what he and the company had said about what they were working on next.
And let's save the "time will tell" bulldhit. 10 years had told us plenty. The names change but the story doesn't.
News 
Market Data 
Discover 
AI
